Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinosarcoma × cediranib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 6 Uterine Cervical Neoplasms 2 Rectal Neoplasms 2 Endometrial Neoplasms 2 Uveal Melanoma 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Pleural Effusion, Malignant 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

Specimen Handling 3 Paclitaxel 3 Nivolumab 3 olaparib 2 X-Rays 2 Carboplatin 2 Biopsy 2 sargramostim 1 pembrolizumab 1 pazopanib 1 pamiparib 1 durvalumab 1 ceralasertib 1 cediranib 1 atezolizumab 1 apatinib 1 Trabectedin 1 Tissue Banks 1 TIC10 compound 1 Minimally Invasive Surgical Procedures 1 Magnetic Resonance Spectroscopy 1 LY-2157299 1 Indocyanine Green 1 Immunoglobulin G 1 Gemcitabine 1 Cyclophosphamide 1 Colony-Stimulating Factors 1 Cisplatin 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570437 2022-03-02

COPELIA

University of Manchester

Phase 2 Unknown

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡